Improving Data Quality and Reducing Site/Patient Burden in Remote Rare…

many assessments in rare disease trials are complex, and remote/hybrid trials readily allow for the use of highly expert centralized raters to administer and score the scales, thereby improving data quality via a decrease in variance and an increase in reliability for data collected

TORONTO (PRWEB) February 28, 2023

Fully remote or hybrid administration of clinical outcome measures in rare disease trials is on the rise. This is because of the recognition that remote assessments reduce patient burden through efforts within the industry to increase enrollment of traditionally underserved populations. Further, many assessments in rare disease trials are complex, and remote/hybrid trials readily allow for the use of highly expert centralized raters to administer and score the scales, thereby improving data quality via a decrease in variance and an increase in reliability for data collected.

While study teams wish to implement these approaches, many are unfamiliar with the operational considerations needed to be successful.

Based on interviews with site staff and key opinion leaders — as well as first-hand experience with remote central rating in many international clinical trials — featured speaker Dr. Pam Ventola will share newly developed guidance for remote centralized rating of standardized rare disease assessments. Attendees will gather best practices to ensure quality and consistent data collection, positive site experiences and patient retention via appropriate scale/technology requirements, schedule of assessments, central rater preparation & training and operational approaches.

Register to gain insights into the newly developed guidance on reducing site/patient burden and improving data quality in remote rare disease trials.

Join Pam Ventola, PhD, Vice President, Science, Cogstate, for the live webinar on Wednesday, March 22, 2023, at 11am EDT (4pm CET/EU-Central).

For more information, or to register for this event, visit Improving Data Quality and Reducing Site/Patient Burden in Remote Rare Disease Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email: